Acetic Acid

Acetic Acid

SCHEMBL832778

CC(=O)O.CC(=O)O.CC(=O)O.OCC(CO)(CO)CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.50
LCK P06239 1/20 0.50
FYN P06241 1/20 0.50
ALDH1A1 P00352 7/20 0.37
TSHR P16473 5/20 0.37
TDP1 Q9NUW8 3/20 0.33
LMNA P02545 2/20 0.33
HIF1A Q16665 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC15A2 Q16348 1/20 0.33
CHRM1 P11229 2/20 0.32
ADRA1A P35348 2/20 0.32
HMGCR P04035 1/20 0.32
TBXA2R P21731 1/20 0.32
TRPA1 O75762 1/20 0.32
THPO P40225 1/20 0.31
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL813642 1.00 FFAR3 (0.50) FFAR3LCKFYNALDH1A1TSHR
Acetic Acid SCHEMBL28959399 1.00 FFAR3 (0.50) FFAR3LCKFYNALDH1A1TSHR
Acetic Acid SCHEMBL725625 1.00 FFAR3 (0.50) FFAR3LCKFYNALDH1A1TSHR
Acetic Acid SCHEMBL2578973 1.00 FFAR3 (0.50) FFAR3LCKFYNALDH1A1TSHR
Acetic Acid SCHEMBL309352 1.00 FFAR3 (0.50) FFAR3LCKFYNALDH1A1TSHR
Acetic Acid SCHEMBL11544701 1.00 FFAR3 (0.50) FFAR3LCKFYNALDH1A1TSHR
Acetic Acid SCHEMBL10338273 1.00 FFAR3 (0.50) FFAR3LCKFYNALDH1A1TSHR
Acetic Acid SCHEMBL27896643 0.91 FFAR3 (0.41) FFAR3LCKFYNALDH1A1TSHR
Acetic Acid SCHEMBL28919486 0.88 FFAR3 (0.39) FFAR3LCKFYNALDH1A1TSHR
Propionic Acid SCHEMBL11588668 0.88 FFAR3 (0.56) FFAR3LCKFYNALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166570-B Aqueous dispersion of resin particles 爱克发-格法特公司 2023-06-02 CN disclosed
CN-115954149-A Torsion-resistant robot arm cable and preparation method thereof 上海古乾智能传输有限公司 2023-04-11 CN disclosed
CN-111199812-B Robot arm is with twisting reverse flexible cable 安徽联嘉祥特种电缆有限公司 2022-05-31 CN disclosed
CN-113227194-A Photosensitive resin composition 日本化药株式会社 2021-08-06 CN disclosed
CN-111199812-A Robot arm is with twisting reverse flexible cable 深圳市联嘉祥科技股份有限公司 2020-05-26 CN disclosed
WO-2020054502-A1 ACTINIC RAY CURABLE COMPOSITION AND FILM USING SAME DIC株式会社 2020-03-19 WO disclosed
US-9567284-B2 Hexaester of mono-formal bis pentaerythritol KH NEOCHEM CO., LTD. (JP) 2017-02-14 US disclosed
US-20160311751-A1 HEXAESTER OF MONO-FORMAL BIS PENTAERYTHRITOL KH NEOCHEM CO., LTD. (JP) 2016-10-27 US disclosed
CN-104822808-B Hexaesters of dipentaerythritol monoformal KH新化株式会社 2016-07-20 CN disclosed
US-9365484-B2 Hexaester of mono-formal bis pentaerythritol KH NEOCHEM CO., LTD. (JP) 2016-06-14 US disclosed
EP-0765862-B1 FATTY ACID ESTER OF ETHERIFIED POLYHYDRIC ALCOHOL KAO CORP (JP) 2000-03-08 EP disclosed
EP-0765862-A1 FATTY ACID ESTER OF ETHERIFIED POLYHYDRIC ALCOHOL Kao Corporation (JP) 1997-04-02 EP disclosed
EP-0363171-B1 Method of and apparatus for forming volume type phase hologram FUJITSU LTD (JP) 1994-02-23 EP disclosed
EP-0363171-A2 Method of and apparatus for forming volume type phase hologram FUJITSU LIMITED (JP) 1990-04-11 EP disclosed
US-4496535-A SHAPE-MEMORY, DIMENSIONAL STABILITY TYNDALE PLAINS-HUNTER, LTD. (US) 1985-01-29 US disclosed
US-4490423-A POLYURETHANE MODIFIED WITH UNSATURATED ESTER TYNDALE PLAINS-HUNTER, LTD. (US) 1984-12-25 US disclosed
EP-0123679-A1 ESTERS OF RETINOIC ACID AND PENTAERYTHRITOL AND MONOBENZAL ACETALS THEREOF SRI INTERNATIONAL (US) 1984-11-07 EP disclosed
US-4464389-A SKIN DISORDERS, ANTITUMOR AGENTS SRI INTERNATIONAL (US) 1984-08-07 US disclosed
US-4454309-A ADDITION-CONDENSATION POILYMERS OF ALLYL OR ACRYLIC ESTERS; CONTACT LENSES; MEDICAL EQUIPMENT TYNDALE PLAINS-HUNTER, LTD. (US) 1984-06-12 US disclosed
WO-1984001573-A1 ESTERS OF RETINOIC ACID AND PENTAERYTHRITOL AND MONOBENZAL ACETALS THEREOF STANFORD RES INST INT (US) 1984-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311751-A1 HEXAESTER OF MONO-FORMAL BIS PENTAERYTHRITOL ELOVL6, ELOVL1, ELOVL3 FFAR3 88/4885LCK 2804/4885FYN 2868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.